Insulet Corporation Sets IPO at 6.7 Million Shares, $14-$16/Share

WASHINGTON, April 25 (Reuters) - Insulet Corp., a medical device company that makes an insulin infusion system, on Wednesday set its planned initial public offering at 6.7 million shares for between $14 and $16 each.

>>> Discuss This Story